A Discussion About a Hematology Career in Industry With Drs. Benjamin Kim and Mark Chao
Dr. Benjamin Kim and Dr. Mark Chao discuss what it's like for a hematologist holding an industry position.
Predicting Responses to Gemtuzumab Ozogamicin
Dr. Raetz looks at the use of gemtuzumab ozogamicin (CO) for the treatment of acute myeloid leukemia in adults and children.
Dr. Gotlib talks about his experience as Editor-in-Chief and welcomes Dr. Laura Michaelis as sixth EC for the publication.
Dr. Linkins reviews the use of IVIg for off-label treatment of severe HIT that has proven refractory to standard measures.
Dr. Abdel-Wahab has a conversation with Drs. Luisa Cimmino and Maher Abdul-Hay about the use of vitamin C to restore TET2 deficiency in leukemia treatment.
November/December 2017 Volume 14, Issue 6
View all Features articles
View all Diffusion articles
Dr. Kenneth Anderson provides an overview of ASH's research agenda including topics such as precision medicine, the state of care for VTE, epigenetic mechanisms, and stem cell biology and regenerative medicine.
View all president's column articles
View all Ask the Hematologist articles
View all Op-Ed articles
View all Mini Review articles
ASH is pleased to see the National Cancer Institute’s (NCI) continuous support for research aimed at accelerating the prevention and treatment of cancers.
ASH submitted comments to the NIH on hematology-related pediatric research that should be included in the NIH's All of Us research program.
After spending months crafting legislation to repeal and
replace the Affordable Care Act (ACA), in late July, the U.S. Senate had its
chance to vote on and pass repeal legislation.
The National Center for Advancing Translational Sciences (NCATS) released a request for information soliciting input on the use of viral vectors as platforms for therapeutic gene delivery to specific organs or cell types, and how such platforms might be developed most efficiently in clinical trials for the treatment of multiple diseases.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology